Facts
The International Equestrian Federation (FEI) alleges Darryl Billing (the Athlete) for a violation of the Anti-Doping Rules for Human Athletes (ADRHA). The Athlete participated at the Bromont International CAI - A, CAN, from 24 to 27 June 2010. On 26 June 2010, the Athlete was selected for in-competition testing.
The analysis revealed the presence of Hydrochlorothiazide which is a Prohibited Substances. Hydrochlorothiazide are "Specified Substances" and are prohibited in- and out-of-competition.
History
On 13 September 2010, the Athlete submitted a formal Standard Therapeutic Use Exemption (TUE) Application form to the FEI, for the daily oral use of Hydrochlorothiazide, Acupril and Quinapril. Together with his TUE application, the Athlete submitted various medical documents and explained that the substances are taken because of high blood pressure. The Athlete further requested that a retroactive TUE be granted to him for the use of Hydrochlorothiazide. The TUE Committee granted the use of the substances as requested by the Athlete, for a period of two (2) years, starting on 15 September 2010.
Considerations panel
It has been established how the specified substance has entered the body of the athlete.
The panel agrees that there was no intention to enhance performances, and a retrospective TUE was granted. But it is regarded as negligence not knowing to have asked for a TUE.
Decision
1. The Athlete shall be formally reprimanded.
2. The Athlete is fined CHF 1500,00.-.
3. As a result of the foregoing/ the Tribunal has decided to disqualify the Athlete from the Event and all medals, points and prize money won at the Event must be forfeited, in accordance with FEI ADRHA Article 9.
Costs
The Athlete shall contribute CHF 1000,00.- towards the legal costs of the legal procedure.
